Waltham-based NeuroMetrix Raising $18.7 Million. See Their Jobs

From New England Tech Wire

Waltham -- NeuroMetrix, a Waltham-based
neurotechnology company, announced that it has obtained commitments from
institutional investors to purchase about $18.7 million of its common stock in a
private placement. The company said it will sell an aggregate of about 8.8
million shares in the deal, for a purchase price of $2.12. Proceeds from the
transaction are expected to be used to expand NeuroMetrix's direct U.S. sales
force, increase its international presence, fund certain clinical outcome
studies, advance its lead potassium channel blocker compound to a Phase I
milestone, as well as for other general working capital purposes, the company
said.
http://www.neurometrix.com

View Jobs at Neurometrix

Note:  At time of posting they are hiring sales people across the US!